Free Trial

Quantbot Technologies LP Grows Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

DENTSPLY SIRONA logo with Medical background
Remove Ads

Quantbot Technologies LP raised its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 852.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 272,849 shares of the medical instruments supplier's stock after purchasing an additional 244,205 shares during the period. Quantbot Technologies LP owned approximately 0.14% of DENTSPLY SIRONA worth $5,179,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Janney Montgomery Scott LLC lifted its holdings in shares of DENTSPLY SIRONA by 45.4% in the 3rd quarter. Janney Montgomery Scott LLC now owns 43,203 shares of the medical instruments supplier's stock worth $1,169,000 after acquiring an additional 13,491 shares during the last quarter. State of New Jersey Common Pension Fund D lifted its stake in DENTSPLY SIRONA by 3.0% in the third quarter. State of New Jersey Common Pension Fund D now owns 78,464 shares of the medical instruments supplier's stock worth $2,123,000 after purchasing an additional 2,305 shares during the last quarter. Venturi Wealth Management LLC boosted its position in DENTSPLY SIRONA by 4,893.5% during the third quarter. Venturi Wealth Management LLC now owns 2,297 shares of the medical instruments supplier's stock valued at $62,000 after buying an additional 2,251 shares during the period. KBC Group NV grew its stake in shares of DENTSPLY SIRONA by 19.9% during the third quarter. KBC Group NV now owns 6,274 shares of the medical instruments supplier's stock valued at $170,000 after buying an additional 1,040 shares during the last quarter. Finally, Connable Office Inc. increased its holdings in shares of DENTSPLY SIRONA by 16.4% in the third quarter. Connable Office Inc. now owns 15,150 shares of the medical instruments supplier's stock worth $410,000 after buying an additional 2,138 shares during the period. Institutional investors own 95.70% of the company's stock.

Remove Ads

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier purchased 15,142 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The shares were bought at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now directly owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.52% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on XRAY shares. Mizuho reduced their price target on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a research report on Thursday, March 13th. Wells Fargo & Company decreased their target price on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a research note on Friday, February 28th. UBS Group dropped their price target on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating for the company in a research report on Tuesday, December 3rd. Robert W. Baird decreased their price objective on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research report on Friday, February 28th. Finally, Morgan Stanley dropped their target price on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating for the company in a report on Tuesday, December 17th. Twelve equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, DENTSPLY SIRONA has a consensus rating of "Hold" and a consensus target price of $23.33.

Read Our Latest Stock Analysis on XRAY

DENTSPLY SIRONA Stock Down 0.5 %

Shares of XRAY stock traded down $0.08 during mid-day trading on Wednesday, reaching $15.66. 2,502,766 shares of the company's stock traded hands, compared to its average volume of 2,976,698. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The company's 50-day moving average price is $18.10 and its 200-day moving average price is $20.67. The company has a market cap of $3.12 billion, a P/E ratio of -7.57, a P/E/G ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA Inc. has a 12 month low of $14.78 and a 12 month high of $33.72.

DENTSPLY SIRONA Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 4.09%. The ex-dividend date is Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -14.07%.

DENTSPLY SIRONA Company Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Recommended Stories

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Should You Invest $1,000 in DENTSPLY SIRONA Right Now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

SoftBank’s latest move is a turnaround for the chip sector; here are 3 chip stocks set to surge. Plus, find a bonus AI stock pick at the end of the video.

Related Videos

3 AI Stocks to Watch After NVIDIA’s Dip

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads